KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Rigel Pharmaceuticals (RIGL) Shares Issued: 2009-2025

Historic Shares Issued for Rigel Pharmaceuticals (RIGL) over the last 14 years, with Sep 2025 value amounting to $4.3 million.

  • Rigel Pharmaceuticals' Shares Issued rose 2603.16% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year increase of 573.91%. This contributed to the annual value of $2.0 million for FY2024, which is 87.23% up from last year.
  • According to the latest figures from Q3 2025, Rigel Pharmaceuticals' Shares Issued is $4.3 million, which was up 921.77% from $418,000 recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Shares Issued registered a high of $4.3 million during Q3 2025, and its lowest value of $1,000 during Q1 2023.
  • For the 3-year period, Rigel Pharmaceuticals' Shares Issued averaged around $744,182, with its median value being $418,000 (2025).
  • Its Shares Issued has fluctuated over the past 5 years, first tumbled by 99.89% in 2023, then spiked by 8,800.00% in 2024.
  • Rigel Pharmaceuticals' Shares Issued (Quarterly) stood at $1.1 million in 2021, then slumped by 46.08% to $585,000 in 2022, then decreased by 16.92% to $486,000 in 2023, then skyrocketed by 201.44% to $1.5 million in 2024, then skyrocketed by 2,603.16% to $4.3 million in 2025.
  • Its Shares Issued stands at $4.3 million for Q3 2025, versus $418,000 for Q2 2025 and $484,000 for Q1 2025.